Abbott Laboratories (ABT) EPS (Weighted Average and Diluted) (2016 - 2025)
Abbott Laboratories (ABT) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $1.02 as the latest value for Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) fell 80.61% to $1.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.73 through Dec 2025, down 51.18% year-over-year, with the annual reading at $3.72 for FY2025, 51.31% down from the prior year.
- EPS (Weighted Average and Diluted) hit $1.02 in Q4 2025 for Abbott Laboratories, up from $0.94 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $5.26 in Q4 2024 to a low of $0.59 in Q4 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged $1.12 across 5 years, with a median of $0.92 in 2023.
- Biggest five-year swings in EPS (Weighted Average and Diluted): surged 478.02% in 2024 and later crashed 80.61% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at $1.11 in 2021, then crashed by 46.85% to $0.59 in 2022, then surged by 54.24% to $0.91 in 2023, then skyrocketed by 478.02% to $5.26 in 2024, then plummeted by 80.61% to $1.02 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for ABT at $1.02 in Q4 2025, $0.94 in Q3 2025, and $1.01 in Q2 2025.